Moloney Securities Asset Management, LLC Moderna, Inc. Transaction History

Moloney Securities Asset Management, LLC

$714 Million
Q3 2024

A detailed history of Moloney Securities Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 10,260 shares of MRNA stock, worth $378,081. This represents 0.1% of its overall portfolio holdings.

Number of Shares

10,260

Previous 5,841 75.65%

Holding current value

$378,081

Previous $693,000 1.15%

% of portfolio

0.1%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$63.64 - $125.14 $281,225 - $552,993	4,419 Added 75.65%	10,260 $685,000
Q2 2024 Jul 30, 2024	SELL	$101.21 - $166.61 $476,091 - $783,733	-4,704 Reduced 44.61%	5,841 $693,000
Q1 2024 May 01, 2024	BUY	$85.37 - $115.44 $233,401 - $315,612	2,734 Added 35.0%	10,545 $1.12 Million
Q4 2023 Jan 30, 2024	BUY	$69.51 - $104.43 $128,593 - $193,195	1,850 Added 31.04%	7,811 $776,000
Q3 2023 Oct 31, 2023	SELL	$96.41 - $126.61 $10,894 - $14,306	-113 Reduced 1.86%	5,961 $615,000
Q2 2023 Jul 31, 2023	SELL	$118.5 - $160.53 $460,017 - $623,177	-3,882 Reduced 38.99%	6,074 $737,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $328,704 - $477,379	-2,423 Reduced 19.57%	9,956 $1.53 Million
Q4 2022 Jan 30, 2023	BUY	$118.38 - $210.04 $84,996 - $150,808	718 Added 6.16%	12,379 $2.22 Million
Q3 2022 Oct 31, 2022	BUY	$118.07 - $194.18 $91,504 - $150,489	775 Added 7.12%	11,661 $1.38 Million
Q2 2022 Aug 03, 2022	SELL	$117.13 - $176.59 $521,228 - $785,825	-4,450 Reduced 29.02%	10,886 $1.56 Million
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $248,873 - $462,578	1,968 Added 14.72%	15,336 $2.64 Million
Q4 2021 Jan 28, 2022	BUY	$225.82 - $368.51 $28,227 - $46,063	125 Added 0.94%	13,368 $3.4 Million
Q3 2021 Oct 27, 2021	SELL	$221.9 - $484.47 $1.03 Million - $2.24 Million	-4,620 Reduced 25.86%	13,243 $5.1 Million
Q2 2021 Jul 26, 2021	BUY	$129.91 - $234.98 $958,086 - $1.73 Million	7,375 Added 70.32%	17,863 $4.2 Million
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $88,981 - $151,573	815 Added 8.43%	10,488 $1.37 Million
Q4 2020 Feb 08, 2021	SELL	$65.74 - $169.86 $27,084 - $69,982	-412 Reduced 4.09%	9,673 $1.01 Million
Q3 2020 Oct 20, 2020	SELL	$54.34 - $94.85 $561,060 - $979,326	-10,325 Reduced 50.59%	10,085 $714,000
Q2 2020 Jul 31, 2020	SELL	$29.67 - $80.0 $449,648 - $1.21 Million	-15,155 Reduced 42.61%	20,410 $1.31 Million
Q1 2020 May 08, 2020	SELL	$17.78 - $31.58 $11,290 - $20,053	-635 Reduced 1.75%	35,565 $1.07 Million
Q4 2019 Feb 06, 2020	SELL	$13.93 - $21.28 $1.43 Million - $2.19 Million	-102,750 Reduced 73.95%	36,200 $708,000
Q3 2019 Nov 01, 2019	BUY	$12.26 - $18.07 $1.03 Million - $1.52 Million	83,875 Added 152.29%	138,950 $2.21 Million
Q2 2019 Jul 29, 2019	BUY	$13.7 - $28.34 $47,086 - $97,404	3,437 Added 6.66%	55,075 $806,000
Q1 2019 May 03, 2019	BUY	$14.45 - $23.7 $746,169 - $1.22 Million	51,638 New	51,638 $1.05 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Account

Moloney Securities Asset Management, LLC Moderna, Inc. Transaction History